ClinicalTrials.Veeva

Menu

Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

U

University Hospital Regensburg

Status

Completed

Conditions

Choroidal Thickness

Study type

Observational

Funder types

Other

Identifiers

NCT01610804
CSCR2011

Details and patient eligibility

About

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Enrollment

18 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with initial diagnosis of CSCR and no treatment so far

Exclusion criteria

  • Therapy (drugs/laser) due to CSCR

Trial design

18 participants in 2 patient groups

CSCR-Patients
Description:
Patients suffering from Central Serous Chorioretinopathy
Healthy Subjects
Description:
Healthy subjects with (assumed) normal choroidal thickness

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems